|
LMFA07050333
|
isopalmitoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(14-methylpentadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 16:0
|
C37H66N7O17P3S
|
1005.344875
|
|
LMFA07050333
|
isopalmitoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(14-methylpentadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 16:0
|
C37H66N7O17P3S
|
1005.344875
|
|
LMFA07050333
|
isopalmitoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(14-methylpentadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 16:0
|
C37H66N7O17P3S
|
1005.344875
|
|
LMFA07050333
|
isopalmitoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(14-methylpentadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 16:0
|
C37H66N7O17P3S
|
1005.344875
|
|
LMFA07050333
|
isopalmitoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(14-methylpentadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 16:0
|
C37H66N7O17P3S
|
1005.344875
|
|
LMFA07050333
|
isopalmitoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(14-methylpentadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 16:0
|
C37H66N7O17P3S
|
1005.344875
|
|
LMFA07070103
|
pivaloylcarnitine
|
3-[(2,2-dimethylpropanoyl)oxy]-4-(trimethylazaniumyl)butanoate
|
CAR 5:0
|
C12H23NO4
|
245.162709
|
|
LMFA07070103
|
pivaloylcarnitine
|
3-[(2,2-dimethylpropanoyl)oxy]-4-(trimethylazaniumyl)butanoate
|
CAR 5:0
|
C12H23NO4
|
245.162709
|
|
LMFA04020064
|
(13R,16S,20S)-d18-14-NeuroF[14S,17S]
|
(R,4Z,7Z,10Z)-13-hydroxy-13-((2S,4S,5S)-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,10-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|